Insulin aspart: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart]. | Insulin aspart, sold under the brand name NovoLog and Fiasp, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. See also [https://en.wikipedia.org/wiki/Insulin_aspart]. | ||
<scene name='96/968809/Cv/4'> | <scene name='96/968809/Cv/4'>Hexamer of the human insulin variant B28Asp at pH 6.5</scene> (PDB ID [[4gbc]]). | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||